JP2009520023A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009520023A5 JP2009520023A5 JP2008547181A JP2008547181A JP2009520023A5 JP 2009520023 A5 JP2009520023 A5 JP 2009520023A5 JP 2008547181 A JP2008547181 A JP 2008547181A JP 2008547181 A JP2008547181 A JP 2008547181A JP 2009520023 A5 JP2009520023 A5 JP 2009520023A5
- Authority
- JP
- Japan
- Prior art keywords
- dopamine
- iron
- pharmaceutically acceptable
- oral administration
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0502830 | 2005-12-20 | ||
| PCT/SE2006/050553 WO2007073325A1 (en) | 2005-12-20 | 2006-12-06 | Method and composition for treating and diagnosing restless legs syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009520023A JP2009520023A (ja) | 2009-05-21 |
| JP2009520023A5 true JP2009520023A5 (https=) | 2010-01-14 |
Family
ID=38188943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008547181A Pending JP2009520023A (ja) | 2005-12-20 | 2006-12-06 | 下肢静止不能症候群を治療及び診断するための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090304816A1 (https=) |
| EP (1) | EP1973551A1 (https=) |
| JP (1) | JP2009520023A (https=) |
| KR (1) | KR20080078075A (https=) |
| CN (1) | CN101336109A (https=) |
| AU (1) | AU2006327254A1 (https=) |
| CA (1) | CA2634140A1 (https=) |
| EA (1) | EA200801540A1 (https=) |
| IL (1) | IL192325A0 (https=) |
| WO (1) | WO2007073325A1 (https=) |
| ZA (1) | ZA200805358B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2646250A1 (en) | 2006-04-03 | 2007-10-18 | Teva Pharmaceutical Industries Ltd. | Use of rasagiline for the treatment of restless legs syndrome |
| US10617694B2 (en) * | 2016-05-11 | 2020-04-14 | Jan Hedner | Sultiame for the treatment of sleep apnea |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US6960571B2 (en) * | 2003-03-14 | 2005-11-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| EP1635804B1 (fr) * | 2003-05-30 | 2016-09-21 | NLS-1 Pharma AG | Utilisation du fer pour le traitement du trouble du deficit de attention/hyper-activite chez les enfants |
| GB0319874D0 (en) * | 2003-08-22 | 2003-09-24 | Glaxo Group Ltd | Novel formulation |
| DE602004031134D1 (de) * | 2003-08-29 | 2011-03-03 | Transform Pharmaceuticals Inc | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa |
-
2006
- 2006-12-06 EA EA200801540A patent/EA200801540A1/ru unknown
- 2006-12-06 EP EP06824619A patent/EP1973551A1/en not_active Withdrawn
- 2006-12-06 AU AU2006327254A patent/AU2006327254A1/en not_active Abandoned
- 2006-12-06 US US12/158,172 patent/US20090304816A1/en not_active Abandoned
- 2006-12-06 WO PCT/SE2006/050553 patent/WO2007073325A1/en not_active Ceased
- 2006-12-06 KR KR1020087017787A patent/KR20080078075A/ko not_active Withdrawn
- 2006-12-06 JP JP2008547181A patent/JP2009520023A/ja active Pending
- 2006-12-06 CN CNA2006800517948A patent/CN101336109A/zh active Pending
- 2006-12-06 CA CA002634140A patent/CA2634140A1/en not_active Abandoned
-
2008
- 2008-06-19 IL IL192325A patent/IL192325A0/en unknown
- 2008-06-19 ZA ZA200805358A patent/ZA200805358B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542246A5 (https=) | ||
| JP2012092127A5 (https=) | ||
| JP2012520883A5 (https=) | ||
| JP2012512907A5 (https=) | ||
| JP2005512995A5 (https=) | ||
| JP2010523587A5 (https=) | ||
| JP2009538832A5 (https=) | ||
| JP2010529118A5 (https=) | ||
| RU2011138490A (ru) | Фармацевтические композиции с мгновенным высвобождением, содержащие оксикодон и налоксон | |
| JP2012255026A5 (https=) | ||
| JP2010090168A5 (https=) | ||
| JP2014532638A5 (https=) | ||
| JP2010529999A5 (https=) | ||
| JP2013543482A5 (https=) | ||
| JP2008543936A5 (https=) | ||
| JP2015044834A5 (https=) | ||
| JP2017525712A5 (https=) | ||
| Chen et al. | Transdermal rotigotine: A clinically innovative dopamine‐receptor agonist for the management of Parkinson's disease | |
| JP2011500658A5 (https=) | ||
| JP2009545603A5 (https=) | ||
| JP2010518086A5 (https=) | ||
| EP3843722B1 (en) | Pharmaceutical composition comprising antiplatelet agent and gastric acid secretion inhibitor | |
| JP2019517587A5 (https=) | ||
| JP2013502446A5 (https=) | ||
| JP2007509146A5 (https=) |